Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Squalamine improves retinal neovascularization.

Higgins RD, Sanders RJ, Yan Y, Zasloff M, Williams JI.

Invest Ophthalmol Vis Sci. 2000 May;41(6):1507-12.

PMID:
10798670
2.

Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy.

Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB.

Curr Eye Res. 1999 Jan;18(1):20-7.

PMID:
10075199
3.

Captopril improves retinal neovascularization via endothelin-1.

Tadesse M, Yan Y, Yossuck P, Higgins RD.

Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1867-72.

PMID:
11431455
4.

Regression of retinopathy by squalamine in a mouse model.

Higgins RD, Yan Y, Geng Y, Zasloff M, Williams JI.

Pediatr Res. 2004 Jul;56(1):144-9. Epub 2004 May 5.

PMID:
15128931
5.

Dexamethasone and critical effect of timing on retinopathy.

Yossuck P, Yan Y, Tadesse M, Higgins RD.

Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3095-9.

PMID:
10967069
6.

The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.

Rabinowitz R, Katz G, Rosner M, Pri-Chen S, Spierer A.

Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):843-8. doi: 10.1007/s00417-008-0781-z. Epub 2008 Mar 15.

PMID:
18343940
7.

Ibuprofen improves oxygen-induced retinopathy in a mouse model.

Sharma J, Barr SM, Geng Y, Yun Y, Higgins RD.

Curr Eye Res. 2003 Nov;27(5):309-14.

PMID:
14562167
8.

T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.

Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M.

Invest Ophthalmol Vis Sci. 2006 May;47(5):2125-34.

PMID:
16639024
9.

RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.

Fang X, Ueno M, Yamashita T, Ikuno Y.

Curr Eye Res. 2011 Nov;36(11):1028-36. doi: 10.3109/02713683.2011.593110.

PMID:
21999228
10.

[Quantification of oxygen-induced retinopathy in the mouse].

Liu Y, Liang X, Xu C, Xie S, Kuang W, Liu Z.

Yan Ke Xue Bao. 2006 Jun;22(2):103-6, 124. Chinese.

PMID:
17162887
11.

Dexamethasone reduces oxygen induced retinopathy in a mouse model.

Rotschild T, Nandgaonkar BN, Yu K, Higgins RD.

Pediatr Res. 1999 Jul;46(1):94-100.

PMID:
10400141
12.

Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.

Unsoeld AS, Junker B, Mazitschek R, Martin G, Hansen LL, Giannis A, Agostini HT.

Mol Vis. 2004 Jul 15;10:468-75.

13.

Increased retinal neovascularization in Fas ligand-deficient mice.

Davies MH, Eubanks JP, Powers MR.

Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3202-10.

PMID:
12824272
14.

Lack of effect of gender on retinopathy in the mouse.

Higgins RD, Yan Y, Tadesse M, Yossuck P.

Clin Experiment Ophthalmol. 2001 Oct;29(5):323-6.

PMID:
11720160
15.

Captopril and vascular endothelial growth factor in a mouse model of retinopathy.

Higgins RD, Yan Y, Geng Y, Sharma J, Barr SM.

Curr Eye Res. 2003 Aug;27(2):123-9.

PMID:
14632165
16.

Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2175-82.

PMID:
15914639
17.

CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.

Franklin AJ, Jetton TL, Kuchemann CL, Russell SR, Kohn EC.

Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3756-66.

PMID:
15452087
18.

[Role of different oxygen concentration and different period of oxygen exposure in pathogenesis of retinopathy in neonatal mice].

Shi WJ, Chen C, Wang YH, Xiao HL, Zhou GM.

Zhonghua Er Ke Za Zhi. 2007 Jan;45(1):14-9. Chinese.

PMID:
17349141
19.

Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.

Elner SG, Elner VM, Yoshida A, Dick RD, Brewer GJ.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):299-303.

PMID:
15623788
20.

The role of Fas-FasL in the development and treatment of ischemic retinopathy.

Barreiro R, Schadlu R, Herndon J, Kaplan HJ, Ferguson TA.

Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1282-6.

PMID:
12601060
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk